Valter Redoglia
About
In The Last Decade
Valter Redoglia
25 papers receiving 787 citations
Peers
Comparison fields: 5 of 62
- Immunology 433
- Molecular Biology 255
- Hematology 246
- Oncology 202
- Physiology 133
Countries citing papers authored by Valter Redoglia
This map shows the geographic impact of Valter Redoglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valter Redoglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valter Redoglia more than expected).
Fields of papers citing papers by Valter Redoglia
This network shows the impact of papers produced by Valter Redoglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valter Redoglia. The network helps show where Valter Redoglia may publish in the future.
Co-authorship network of co-authors of Valter Redoglia
This figure shows the co-authorship network connecting the top 25 collaborators of Valter Redoglia. A scholar is included among the top collaborators of Valter Redoglia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valter Redoglia. Valter Redoglia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 35 | |
| 4 | 24 | |
| 5 | 26 | |
| 6 | 137 | |
| 7 | 52 | |
| 8 | 44 | |
| 9 | 81 | |
| 10 | 38 | |
| 11 | 60 | |
| 12 | 4 | |
| 13 | 58 | |
| 14 | 15 | |
| 15 | 4 | |
| 16 | Emergence of activated lymphocytes in CD4 and CD8 subpopulations of multiple myeloma: correlation with the expansion of suppressor T-cells (CD8+ OKM1+) and ecto-5'nucleotidase deficiency. | 10 |
| 17 | 14 | |
| 18 | 4 | |
| 19 | 15 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.